BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
461.79599
NSE Symbol
NATCOPHARM
Divident Yield %
0.73
Market Cap
(Rs In Cr.)
14,725
P/E (TTM)
9.7
EPS (TTM)
84.75
Face Value
(Rs)
2
Back
Natco Pharma consolidated net profit rises 13.91% in the December 2025 quarter
12-Feb-26   Hrs IST

Net profit of Natco Pharma rose 13.91% to Rs 151.50 crore in the quarter ended December 2025 as against Rs 133.00 crore during the previous quarter ended December 2024. Sales rose 36.33% to Rs 647.30 crore in the quarter ended December 2025 as against Rs 474.80 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales647.30474.80 36
OPM %24.528.17 -
PBDT207.30210.70 -2
PBT161.10163.70 -2
NP151.50133.00 14

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)